ALLISON MISKAWITZ: Open Payments
NPI 1033728571 · BERKLEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,489 in 76 payments from 19 companies in 2025. Trend: 2023 $282 · 2024 $1,423 · 2025 $1,489
Food & beverage: $1,389Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $309 |
| Novartis Pharmaceuticals Corporation | 17 | $201 |
| ABBVIE INC. | 10 | $162 |
| Incyte Corporation | 9 | $162 |
| LEO Pharma Inc. | 6 | $125 |
| GENZYME CORPORATION | 3 | $80 |
| UCB, Inc. | 3 | $73 |
| NOBELPHARMA AMERICA, LLC | 3 | $66 |
| PFIZER INC. | 3 | $65 |
| Krystal Biotech Inc | 2 | $42 |
Products named: TREMFYA, COSENTYX, OPZELURA, DUPIXENT, RINVOQ, ADBRY, SKYRIZI, Bimzelx.
Industry payments across MI — which companies pay providers there.
